- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03375320
Testa Cabozantinib hos patienter med avancerad pankreatisk neuroendokrina och karcinoida tumörer
Randomiserad, dubbelblind fas III-studie av Cabozantinib kontra placebo hos patienter med avancerade neuroendokrina tumörer efter progression av tidigare terapi (CABINET)
This phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may slow tumor growth.
Studieöversikt
Status
Betingelser
- Neuroendokrin tumör
- Fungerande pankreatisk neuroendokrin tumör
- Neuroendokrin neoplasm i lungan av medelgrad
- Lokalt avancerad pankreatisk neuroendokrin tumör
- Lokalt avancerad, icke-resecerbar matsmältningssystemet Neuroendokrin neoplasma
- Låggradig lungneuroendokrin neoplasm
- Metastaserande matsmältningssystemet Neuroendokrin neoplasma
- Metastaserande matsmältningssystemet Neuroendokrina tumörer G1
- Metastaserande pankreatisk neuroendokrin tumör
- Neuroendokrin neoplasma
- Icke-fungerande pankreatisk neuroendokrin tumör
- Pankreatisk serotoninproducerande neuroendokrin tumör
- Lokalt avancerad lungneuroendokrin neoplasma
- Metastaserande lungneuroendokrin neoplasma
- Obegreppbar lungneuroendokrin neoplasma
- Lokalt avancerad matsmältningssystemet Neuroendokrin neoplasma
- Lokalt avancerad matsmältningssystemet Neuroendokrina tumörer G1
- Metastaserande pankreatisk neuroendokrin neoplasma
- Obegreppbart matsmältningssystemet Neuroendokrin neoplasma
- Obegreppbart matsmältningssystemet Neuroendokrina tumörer G1
- Obegreppbar pankreatisk neuroendokrin neoplasma
- Lung neuroendokrin tumör G2
- Metastaserande lungneuroendokrin tumör
- Lung neuroendokrin tumör
- Neuroendokrin tumör G2
- Metastaserande Thymus Neuroendokrin Neoplasm
- Thymus neuroendokrin tumör
- Obegreppbar Thymus Neuroendokrin Neoplasm
Detaljerad beskrivning
PRIMARY OBJECTIVES:
I. To determine whether cabozantinib (cabozantinib S-malate) can significantly improve progression-free survival (PFS) compared to placebo in patients with advanced pancreatic neuroendocrine tumors (NET) whose disease has progressed after prior therapy.
II. To determine whether cabozantinib can significantly improve progression-free survival (PFS) compared to placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.
SECONDARY OBJECTIVES:
I. To determine whether cabozantinib can significantly improve overall survival (OS) compared to placebo in patients with advanced pancreatic NET whose disease has progressed after prior therapy.
II. To determine whether cabozantinib can significantly improve overall survival (OS) compared to placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.
III. To evaluate safety and tolerability of cabozantinib versus placebo in patients with advanced pancreatic NET using Common Terminology Criteria for Adverse Events (CTCAE) and Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
IV. To evaluate safety and tolerability of cabozantinib versus placebo in patients with advanced carcinoid tumors using CTCAE and PRO-CTCAE.
V. To evaluate the overall radiographic response rate of cabozantinib versus placebo in patients with advanced pancreatic NET whose disease has progressed after prior therapy.
VI. To evaluate the overall radiographic response rate of cabozantinib versus placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.
OTHER OBJECTIVE:
I. Results of the primary analysis will be examined for consistency, while taking into account the stratification factors and/or covariates of baseline quality of life (QOL) and fatigue.
QUALITY OF LIFE SUBSTUDY OBJECTIVE:
I. To compare overall quality of life, disease-related symptoms, and other domains between the two treatment groups (cabozantinib versus [vs.] placebo) within each cohort of patients (pancreatic NET vs. carcinoid tumor). (Quality of Life Substudy Objective - A021602-HO1)
POPULATION PHARMACOKINETICS SUBSTUDY OBJECTIVE:
I. To describe the population pharmacokinetic and exposure-response relationships of cabozantinib in patients with advanced neuroendocrine tumors. (Population Pharmacokinetics Substudy Objective - A021602-PP1)
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive cabozantinib S-malate orally (PO) once daily (QD) on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and computed tomography (CT), magnetic resonance imaging (MRI), and/or x-ray imaging during screening and on study.
ARM II: Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression.
After completion of study treatment, patients are followed up every 12 weeks until disease progression or start of new anticancer therapy, and then every 6 months until 8 years after registration.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 3
Kontakter och platser
Studieorter
-
-
Alaska
-
Anchorage, Alaska, Förenta staterna, 99508
- Katmai Oncology Group
-
-
Arizona
-
Kingman, Arizona, Förenta staterna, 86401
- Kingman Regional Medical Center
-
Phoenix, Arizona, Förenta staterna, 85054
- Mayo Clinic Hospital in Arizona
-
Tucson, Arizona, Förenta staterna, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Förenta staterna, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Little Rock, Arkansas, Förenta staterna, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Antioch, California, Förenta staterna, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Arroyo Grande, California, Förenta staterna, 93420
- PCR Oncology
-
Auburn, California, Förenta staterna, 95602
- Sutter Auburn Faith Hospital
-
Berkeley, California, Förenta staterna, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Burlingame, California, Förenta staterna, 94010
- Mills-Peninsula Medical Center
-
Duarte, California, Förenta staterna, 91010
- City of Hope Comprehensive Cancer Center
-
Dublin, California, Förenta staterna, 94568
- Epic Care-Dublin
-
Emeryville, California, Förenta staterna, 94608
- Epic Care Partners in Cancer Care
-
Fremont, California, Förenta staterna, 94538
- Kaiser Permanente-Fremont
-
Fremont, California, Förenta staterna, 94538
- Palo Alto Medical Foundation-Fremont
-
Fresno, California, Förenta staterna, 93720
- Kaiser Permanente-Fresno
-
Martinez, California, Förenta staterna, 94553-3156
- Contra Costa Regional Medical Center
-
Marysville, California, Förenta staterna, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, Förenta staterna, 95355
- Memorial Medical Center
-
Modesto, California, Förenta staterna, 95356
- Kaiser Permanente-Modesto
-
Mountain View, California, Förenta staterna, 94040
- Palo Alto Medical Foundation-Camino Division
-
Oakland, California, Förenta staterna, 94611
- Kaiser Permanente-Oakland
-
Oakland, California, Förenta staterna, 94609
- Alta Bates Summit Medical Center - Summit Campus
-
Palo Alto, California, Förenta staterna, 94304
- Stanford Cancer Institute Palo Alto
-
Palo Alto, California, Förenta staterna, 94301
- Palo Alto Medical Foundation Health Care
-
Redwood City, California, Förenta staterna, 94063
- Kaiser Permanente-Redwood City
-
Richmond, California, Förenta staterna, 94801
- Kaiser Permanente-Richmond
-
Roseville, California, Förenta staterna, 95661
- Kaiser Permanente-Roseville
-
Roseville, California, Förenta staterna, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, Förenta staterna, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Förenta staterna, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, Förenta staterna, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, Förenta staterna, 95823
- Kaiser Permanente-South Sacramento
-
Salinas, California, Förenta staterna, 93901
- Salinas Valley Memorial
-
San Francisco, California, Förenta staterna, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Förenta staterna, 94158
- UCSF Medical Center-Mission Bay
-
San Francisco, California, Förenta staterna, 94115
- California Pacific Medical Center-Pacific Campus
-
San Jose, California, Förenta staterna, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro, California, Förenta staterna, 94577
- Kaiser Permanente San Leandro
-
San Mateo, California, Förenta staterna, 94401
- Mills Health Center
-
San Rafael, California, Förenta staterna, 94903
- Kaiser San Rafael-Gallinas
-
San Rafael, California, Förenta staterna, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Förenta staterna, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Cruz, California, Förenta staterna, 95065
- Palo Alto Medical Foundation-Santa Cruz
-
Santa Rosa, California, Förenta staterna, 95403
- Kaiser Permanente-Santa Rosa
-
South San Francisco, California, Förenta staterna, 94080
- Kaiser Permanente-South San Francisco
-
Stockton, California, Förenta staterna, 95210
- Kaiser Permanente-Stockton
-
Sunnyvale, California, Förenta staterna, 94086
- Palo Alto Medical Foundation-Sunnyvale
-
Vacaville, California, Förenta staterna, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Förenta staterna, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, Förenta staterna, 94589
- Sutter Solano Medical Center/Cancer Center
-
Walnut Creek, California, Förenta staterna, 94596
- Kaiser Permanente-Walnut Creek
-
-
Colorado
-
Aurora, Colorado, Förenta staterna, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Boulder, Colorado, Förenta staterna, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Colorado Springs, Colorado, Förenta staterna, 80907
- Penrose-Saint Francis Healthcare
-
Denver, Colorado, Förenta staterna, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Förenta staterna, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Förenta staterna, 80206
- National Jewish Health-Main Campus
-
Denver, Colorado, Förenta staterna, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Englewood, Colorado, Förenta staterna, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, Förenta staterna, 80113
- Swedish Medical Center
-
Golden, Colorado, Förenta staterna, 80401
- National Jewish Health-Western Hematology Oncology
-
Grand Junction, Colorado, Förenta staterna, 81501
- Saint Mary's Hospital and Regional Medical Center
-
Greeley, Colorado, Förenta staterna, 80631
- Banner North Colorado Medical Center
-
Lafayette, Colorado, Förenta staterna, 80026
- Good Samaritan Hospital - Cancer Centers of Colorado
-
Littleton, Colorado, Förenta staterna, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree, Colorado, Förenta staterna, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Loveland, Colorado, Förenta staterna, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Thornton, Colorado, Förenta staterna, 80260
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge, Colorado, Förenta staterna, 80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Danbury, Connecticut, Förenta staterna, 06810
- Danbury Hospital
-
Norwalk, Connecticut, Förenta staterna, 06856
- Norwalk Hospital
-
-
District of Columbia
-
Washington D.C., District of Columbia, Förenta staterna, 20007
- MedStar Georgetown University Hospital
-
-
Florida
-
Aventura, Florida, Förenta staterna, 33180
- GenesisCare USA - Aventura FP
-
Aventura, Florida, Förenta staterna, 33180
- GenesisCare USA - Aventura
-
Boca Raton, Florida, Förenta staterna, 33431
- GenesisCare USA - Boca Ration FP06
-
Fort Myers, Florida, Förenta staterna, 33905
- Regional Cancer Center-Lee Memorial Health System
-
Hollywood, Florida, Förenta staterna, 33021
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital
-
Jacksonville, Florida, Förenta staterna, 32224-9980
- Mayo Clinic in Florida
-
Tampa, Florida, Förenta staterna, 33612
- Moffitt Cancer Center
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Förenta staterna, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, Förenta staterna, 30342
- Emory Saint Joseph's Hospital
-
-
Hawaii
-
Honolulu, Hawaii, Förenta staterna, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Förenta staterna, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Förenta staterna, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, Förenta staterna, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Förenta staterna, 96817
- Queen's Cancer Center - Kuakini
-
Honolulu, Hawaii, Förenta staterna, 96819
- Kaiser Permanente Moanalua Medical Center
-
‘Aiea, Hawaii, Förenta staterna, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, Förenta staterna, 96701
- Pali Momi Medical Center
-
-
Idaho
-
Boise, Idaho, Förenta staterna, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Förenta staterna, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Förenta staterna, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Förenta staterna, 83814
- Kootenai Health - Coeur d'Alene
-
Emmett, Idaho, Förenta staterna, 83617
- Walter Knox Memorial Hospital
-
Fruitland, Idaho, Förenta staterna, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Förenta staterna, 83642
- Idaho Urologic Institute-Meridian
-
Meridian, Idaho, Förenta staterna, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Förenta staterna, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Förenta staterna, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Förenta staterna, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Förenta staterna, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Förenta staterna, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Bloomington, Illinois, Förenta staterna, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Förenta staterna, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, Förenta staterna, 62321
- Illinois CancerCare-Carthage
-
Chicago, Illinois, Förenta staterna, 60637
- University of Chicago Comprehensive Cancer Center
-
Chicago, Illinois, Förenta staterna, 60612
- University of Illinois
-
Danville, Illinois, Förenta staterna, 61832
- Carle at The Riverfront
-
Decatur, Illinois, Förenta staterna, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon, Illinois, Förenta staterna, 61021
- Illinois CancerCare-Dixon
-
Effingham, Illinois, Förenta staterna, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, Förenta staterna, 62401
- Carle Physician Group-Effingham
-
Eureka, Illinois, Förenta staterna, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Förenta staterna, 61401
- Illinois CancerCare-Galesburg
-
Kewanee, Illinois, Förenta staterna, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, Förenta staterna, 61455
- Illinois CancerCare-Macomb
-
Mattoon, Illinois, Förenta staterna, 61938
- Carle Physician Group-Mattoon/Charleston
-
Maywood, Illinois, Förenta staterna, 60153
- Loyola University Medical Center
-
New Lenox, Illinois, Förenta staterna, 60451
- UC Comprehensive Cancer Center at Silver Cross
-
O'Fallon, Illinois, Förenta staterna, 62269
- Cancer Care Center of O'Fallon
-
Orland Park, Illinois, Förenta staterna, 60462
- University of Chicago Medicine-Orland Park
-
Ottawa, Illinois, Förenta staterna, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, Förenta staterna, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Förenta staterna, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Förenta staterna, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Förenta staterna, 61356
- Illinois CancerCare-Princeton
-
Springfield, Illinois, Förenta staterna, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Förenta staterna, 62702
- Springfield Clinic
-
Urbana, Illinois, Förenta staterna, 61801
- Carle Cancer Center
-
Washington, Illinois, Förenta staterna, 61571
- Illinois CancerCare - Washington
-
-
Indiana
-
South Bend, Indiana, Förenta staterna, 46601
- Memorial Hospital of South Bend
-
-
Iowa
-
Bettendorf, Iowa, Förenta staterna, 52722
- University of Iowa Healthcare Cancer Services Quad Cities
-
Cedar Rapids, Iowa, Förenta staterna, 52403
- Mercy Hospital
-
Cedar Rapids, Iowa, Förenta staterna, 52403
- Oncology Associates at Mercy Medical Center
-
Clive, Iowa, Förenta staterna, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Förenta staterna, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Council Bluffs, Iowa, Förenta staterna, 51503
- Heartland Oncology and Hematology LLP
-
Council Bluffs, Iowa, Förenta staterna, 51503
- Methodist Jennie Edmundson Hospital
-
Creston, Iowa, Förenta staterna, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, Förenta staterna, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Förenta staterna, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Förenta staterna, 50314
- Broadlawns Medical Center
-
Des Moines, Iowa, Förenta staterna, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Förenta staterna, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Fort Dodge, Iowa, Förenta staterna, 50501
- UI Healthcare Mission Cancer and Blood - Fort Dodge
-
Iowa City, Iowa, Förenta staterna, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
West Des Moines, Iowa, Förenta staterna, 50266
- Mercy Medical Center-West Lakes
-
-
Kentucky
-
Lexington, Kentucky, Förenta staterna, 40536
- University of Kentucky/Markey Cancer Center
-
-
Louisiana
-
Baton Rouge, Louisiana, Förenta staterna, 70805
- LSU Health Baton Rouge-North Clinic
-
Baton Rouge, Louisiana, Förenta staterna, 70809
- Louisiana Hematology Oncology Associates LLC
-
Baton Rouge, Louisiana, Förenta staterna, 70809
- Mary Bird Perkins Cancer Center
-
Baton Rouge, Louisiana, Förenta staterna, 70808
- Our Lady of The Lake
-
Baton Rouge, Louisiana, Förenta staterna, 70808
- Our Lady of the Lake Physician Group
-
Covington, Louisiana, Förenta staterna, 70433
- Northshore Oncology Associates-Covington
-
Houma, Louisiana, Förenta staterna, 70360
- Oncology Center of The South Incorporated
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Förenta staterna, 02215
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, Förenta staterna, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, Förenta staterna, 02118
- Boston Medical Center
-
Burlington, Massachusetts, Förenta staterna, 01805
- Lahey Clinic
-
-
Michigan
-
Adrian, Michigan, Förenta staterna, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Förenta staterna, 48109
- University of Michigan Rogel Cancer Center
-
Ann Arbor, Michigan, Förenta staterna, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek, Michigan, Förenta staterna, 49017
- Bronson Battle Creek
-
Brighton, Michigan, Förenta staterna, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Förenta staterna, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, Förenta staterna, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Förenta staterna, 48188
- Trinity Health Medical Center - Canton
-
Caro, Michigan, Förenta staterna, 48723
- Caro Cancer Center
-
Chelsea, Michigan, Förenta staterna, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Förenta staterna, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Förenta staterna, 48346
- McLaren Cancer Institute-Clarkston
-
Clarkston, Michigan, Förenta staterna, 48346
- Hematology Oncology Consultants-Clarkston
-
Clarkston, Michigan, Förenta staterna, 48346
- Newland Medical Associates-Clarkston
-
Detroit, Michigan, Förenta staterna, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Förenta staterna, 48201
- Wayne State University/Karmanos Cancer Institute
-
Detroit, Michigan, Förenta staterna, 48236
- Henry Ford Health Saint John Hospital
-
East China Township, Michigan, Förenta staterna, 48054
- Henry Ford River District Hospital
-
Farmington Hills, Michigan, Förenta staterna, 48334
- Weisberg Cancer Treatment Center
-
Flint, Michigan, Förenta staterna, 48532
- McLaren Cancer Institute-Flint
-
Flint, Michigan, Förenta staterna, 48532
- Singh and Arora Hematology Oncology PC
-
Flint, Michigan, Förenta staterna, 48503
- Hurley Medical Center
-
Flint, Michigan, Förenta staterna, 48503
- Genesee Hematology Oncology PC
-
Flint, Michigan, Förenta staterna, 48503
- Genesys Hurley Cancer Institute
-
Flint, Michigan, Förenta staterna, 48503
- Cancer Hematology Centers - Flint
-
Grosse Pointe Woods, Michigan, Förenta staterna, 48236
- Henry Ford Saint John Hospital - Academic
-
Grosse Pointe Woods, Michigan, Förenta staterna, 48236
- Henry Ford Saint John Hospital - Breast
-
Grosse Pointe Woods, Michigan, Förenta staterna, 48236
- Henry Ford Saint John Hospital - Van Elslander
-
Kalamazoo, Michigan, Förenta staterna, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Förenta staterna, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Förenta staterna, 49009
- Beacon Kalamazoo Cancer Center
-
Lansing, Michigan, Förenta staterna, 48910
- Karmanos Cancer Institute at McLaren Greater Lansing
-
Lansing, Michigan, Förenta staterna, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Förenta staterna, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Livonia, Michigan, Förenta staterna, 48154
- Hope Cancer Clinic
-
Macomb, Michigan, Förenta staterna, 48044
- Henry Ford Warren Hospital - Breast Macomb
-
Macomb, Michigan, Förenta staterna, 48044
- Henry Ford Saint John Hospital - Macomb Medical
-
Marlette, Michigan, Förenta staterna, 48453
- Saint Mary's Oncology/Hematology Associates of Marlette
-
Monroe, Michigan, Förenta staterna, 48162
- Toledo Clinic Cancer Centers-Monroe
-
Mount Clemens, Michigan, Förenta staterna, 48043
- McLaren Cancer Institute-Macomb
-
Mount Pleasant, Michigan, Förenta staterna, 48858
- McLaren Cancer Institute-Central Michigan
-
Petoskey, Michigan, Förenta staterna, 49770
- McLaren Cancer Institute-Northern Michigan
-
Pontiac, Michigan, Förenta staterna, 48341
- Hope Cancer Center
-
Pontiac, Michigan, Förenta staterna, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, Förenta staterna, 48341
- Michigan Healthcare Professionals Pontiac
-
Pontiac, Michigan, Förenta staterna, 48341
- Trinity Health IHA Medical Group-Alice Gustafson Center
-
Port Huron, Michigan, Förenta staterna, 48060
- McLaren-Port Huron
-
Port Huron, Michigan, Förenta staterna, 48060
- Lake Huron Medical Center
-
Port Huron, Michigan, Förenta staterna, 48060
- Huron Medical Center PC
-
Rochester Hills, Michigan, Förenta staterna, 48309
- Henry Ford Rochester Hospital
-
Saginaw, Michigan, Förenta staterna, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Förenta staterna, 48601
- MyMichigan Medical Center Saginaw
-
Sterling Heights, Michigan, Förenta staterna, 48312
- Bhadresh Nayak MD PC-Sterling Heights
-
Tawas City, Michigan, Förenta staterna, 48764
- MyMichigan Medical Center Tawas
-
Warren, Michigan, Förenta staterna, 48088
- Advanced Breast Care Center PLLC
-
Warren, Michigan, Förenta staterna, 48093
- Macomb Hematology Oncology PC
-
Warren, Michigan, Förenta staterna, 48093
- Henry Ford Madison Heights Hospital - Breast
-
Warren, Michigan, Förenta staterna, 48093
- Henry Ford Health Warren Hospital
-
Warren, Michigan, Förenta staterna, 48093
- Henry Ford Warren Hospital - GLCMS
-
West Branch, Michigan, Förenta staterna, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Ypsilanti, Michigan, Förenta staterna, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
Ypsilanti, Michigan, Förenta staterna, 48106
- Huron Gastroenterology PC
-
-
Minnesota
-
Bemidji, Minnesota, Förenta staterna, 56601
- Sanford Joe Lueken Cancer Center
-
Burnsville, Minnesota, Förenta staterna, 55337
- Fairview Ridges Hospital
-
Burnsville, Minnesota, Förenta staterna, 55337
- Minnesota Oncology - Burnsville
-
Coon Rapids, Minnesota, Förenta staterna, 55433
- Mercy Hospital
-
Deer River, Minnesota, Förenta staterna, 56636
- Essentia Health - Deer River Clinic
-
Duluth, Minnesota, Förenta staterna, 55805
- Essentia Health Cancer Center
-
Edina, Minnesota, Förenta staterna, 55435
- Fairview Southdale Hospital
-
Fridley, Minnesota, Förenta staterna, 55432
- Unity Hospital
-
Hibbing, Minnesota, Förenta staterna, 55746
- Essentia Health Hibbing Clinic
-
Maple Grove, Minnesota, Förenta staterna, 55369
- Fairview Clinics and Surgery Center Maple Grove
-
Maplewood, Minnesota, Förenta staterna, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Förenta staterna, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Förenta staterna, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Förenta staterna, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Förenta staterna, 55454
- Health Partners Inc
-
New Ulm, Minnesota, Förenta staterna, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, Förenta staterna, 55422
- North Memorial Medical Health Center
-
Rochester, Minnesota, Förenta staterna, 55905
- Mayo Clinic in Rochester
-
Saint Louis Park, Minnesota, Förenta staterna, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Förenta staterna, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Förenta staterna, 55102
- United Hospital
-
Sandstone, Minnesota, Förenta staterna, 55072
- Essentia Health Sandstone
-
Shakopee, Minnesota, Förenta staterna, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Förenta staterna, 55082
- Lakeview Hospital
-
Virginia, Minnesota, Förenta staterna, 55792
- Essentia Health Virginia Clinic
-
Waconia, Minnesota, Förenta staterna, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Förenta staterna, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Förenta staterna, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
Wyoming, Minnesota, Förenta staterna, 55092
- Fairview Lakes Medical Center
-
-
Missouri
-
Bonne Terre, Missouri, Förenta staterna, 63628
- Parkland Health Center-Bonne Terre
-
Cape Girardeau, Missouri, Förenta staterna, 63703
- Saint Francis Medical Center
-
City of Saint Peters, Missouri, Förenta staterna, 63376
- Siteman Cancer Center at Saint Peters Hospital
-
Creve Coeur, Missouri, Förenta staterna, 63141
- Siteman Cancer Center at West County Hospital
-
Farmington, Missouri, Förenta staterna, 63640
- Parkland Health Center - Farmington
-
Sainte Genevieve, Missouri, Förenta staterna, 63670
- Sainte Genevieve County Memorial Hospital
-
St Louis, Missouri, Förenta staterna, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Förenta staterna, 63129
- Siteman Cancer Center-South County
-
St Louis, Missouri, Förenta staterna, 63136
- Siteman Cancer Center at Christian Hospital
-
St Louis, Missouri, Förenta staterna, 63131
- Missouri Baptist Medical Center
-
Sullivan, Missouri, Förenta staterna, 63080
- Missouri Baptist Sullivan Hospital
-
-
Montana
-
Anaconda, Montana, Förenta staterna, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Förenta staterna, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Förenta staterna, 59102
- Saint Vincent Frontier Cancer Center
-
Bozeman, Montana, Förenta staterna, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, Förenta staterna, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, Förenta staterna, 59405
- Great Falls Clinic
-
Great Falls, Montana, Förenta staterna, 59405
- Benefis Sletten Cancer Institute
-
Helena, Montana, Förenta staterna, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, Förenta staterna, 59901
- Logan Health Medical Center
-
Missoula, Montana, Förenta staterna, 59804
- Community Medical Center
-
-
Nebraska
-
Grand Island, Nebraska, Förenta staterna, 68803
- Nebraska Cancer Specialists/Oncology Hematology West PC
-
Omaha, Nebraska, Förenta staterna, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, Förenta staterna, 68114
- Oncology Associates PC
-
Omaha, Nebraska, Förenta staterna, 68114
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
-
-
Nevada
-
Carson City, Nevada, Förenta staterna, 89703
- Carson Tahoe Regional Medical Center
-
Henderson, Nevada, Förenta staterna, 89052
- Comprehensive Cancer Centers of Nevada - Henderson
-
Henderson, Nevada, Förenta staterna, 89052
- Cancer and Blood Specialists-Henderson
-
Henderson, Nevada, Förenta staterna, 89052
- Las Vegas Cancer Center-Henderson
-
Henderson, Nevada, Förenta staterna, 89074
- Comprehensive Cancer Centers of Nevada-Southeast Henderson
-
Henderson, Nevada, Förenta staterna, 89052
- Comprehensive Cancer Centers of Nevada-Horizon Ridge
-
Henderson, Nevada, Förenta staterna, 89074
- Oncology Las Vegas - Henderson
-
Las Vegas, Nevada, Förenta staterna, 89144
- Summerlin Hospital Medical Center
-
Las Vegas, Nevada, Förenta staterna, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Förenta staterna, 89106
- Radiation Oncology Centers of Nevada Central
-
Las Vegas, Nevada, Förenta staterna, 89119
- Radiation Oncology Centers of Nevada Southeast
-
Las Vegas, Nevada, Förenta staterna, 89128
- Comprehensive Cancer Centers of Nevada - Northwest
-
Las Vegas, Nevada, Förenta staterna, 89128
- OptumCare Cancer Care at MountainView
-
Las Vegas, Nevada, Förenta staterna, 89144
- Comprehensive Cancer Centers of Nevada-Summerlin
-
Las Vegas, Nevada, Förenta staterna, 89148
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, Förenta staterna, 89169
- Comprehensive Cancer Centers of Nevada - Central Valley
-
Las Vegas, Nevada, Förenta staterna, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, Förenta staterna, 89106
- Cancer and Blood Specialists-Shadow
-
Las Vegas, Nevada, Förenta staterna, 89109
- HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
-
Las Vegas, Nevada, Förenta staterna, 89113
- HealthCare Partners Medical Group Oncology/Hematology-San Martin
-
Las Vegas, Nevada, Förenta staterna, 89121
- Cancer Therapy and Integrative Medicine
-
Las Vegas, Nevada, Förenta staterna, 89128
- Cancer and Blood Specialists-Tenaya
-
Las Vegas, Nevada, Förenta staterna, 89128
- HealthCare Partners Medical Group Oncology/Hematology-Tenaya
-
Las Vegas, Nevada, Förenta staterna, 89148-2405
- Las Vegas Cancer Center-Medical Center
-
Las Vegas, Nevada, Förenta staterna, 89149
- HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
-
Las Vegas, Nevada, Förenta staterna, 89128
- Ann M Wierman MD LTD
-
Las Vegas, Nevada, Förenta staterna, 89102
- Desert West Surgery
-
Las Vegas, Nevada, Förenta staterna, 89103
- Hope Cancer Care of Nevada
-
Las Vegas, Nevada, Förenta staterna, 89169
- University Cancer Center
-
Las Vegas, Nevada, Förenta staterna, 89128
- Oncology Las Vegas - Tenaya
-
Las Vegas, Nevada, Förenta staterna, 89183
- OptumCare Cancer Care at Fort Apache
-
Pahrump, Nevada, Förenta staterna, 89048
- Hope Cancer Care of Nevada-Pahrump
-
Reno, Nevada, Förenta staterna, 89502
- Renown Regional Medical Center
-
Reno, Nevada, Förenta staterna, 89503
- Saint Mary's Regional Medical Center
-
Reno, Nevada, Förenta staterna, 89509
- Radiation Oncology Associates
-
-
New Hampshire
-
Lebanon, New Hampshire, Förenta staterna, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Nashua, New Hampshire, Förenta staterna, 03063
- Dartmouth Cancer Center - Nashua
-
-
New Jersey
-
Basking Ridge, New Jersey, Förenta staterna, 07920
- Memorial Sloan Kettering Basking Ridge
-
Englewood, New Jersey, Förenta staterna, 07631
- Englewood Hospital and Medical Center
-
Middletown, New Jersey, Förenta staterna, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, Förenta staterna, 07645
- Memorial Sloan Kettering Bergen
-
Paramus, New Jersey, Förenta staterna, 07652
- The Valley Hospital - Luckow Pavilion
-
Ridgewood, New Jersey, Förenta staterna, 07450
- Valley Health System Ridgewood Campus
-
Wayne, New Jersey, Förenta staterna, 07470
- Valley Medical Group - Wayne Multispecialty Practice
-
-
New Mexico
-
Albuquerque, New Mexico, Förenta staterna, 87109
- New Mexico Oncology Hematology Consultants
-
Albuquerque, New Mexico, Förenta staterna, 87106
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, Förenta staterna, 87110
- Presbyterian Kaseman Hospital
-
Rio Rancho, New Mexico, Förenta staterna, 87124
- Presbyterian Rust Medical Center/Jorgensen Cancer Center
-
-
New York
-
Auburn, New York, Förenta staterna, 13021
- Hematology Oncology Associates of Central New York-Auburn
-
Buffalo, New York, Förenta staterna, 14263
- Roswell Park Cancer Institute
-
Camillus, New York, Förenta staterna, 13031
- Hematology Oncology Associates of CNY at Camillus
-
Commack, New York, Förenta staterna, 11725
- Memorial Sloan Kettering Commack
-
East Syracuse, New York, Förenta staterna, 13057
- Hematology Oncology Associates of Central New York-East Syracuse
-
Harrison, New York, Förenta staterna, 10604
- Memorial Sloan Kettering Westchester
-
New York, New York, Förenta staterna, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, Förenta staterna, 10029
- Mount Sinai Hospital
-
Rochester, New York, Förenta staterna, 14642
- University of Rochester
-
Uniondale, New York, Förenta staterna, 11553
- Memorial Sloan Kettering Nassau
-
Webster, New York, Förenta staterna, 14580
- Wilmot Cancer Institute at Webster
-
-
North Carolina
-
Chapel Hill, North Carolina, Förenta staterna, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Clinton, North Carolina, Förenta staterna, 28328
- Southeastern Medical Oncology Center-Clinton
-
Goldsboro, North Carolina, Förenta staterna, 27534
- Southeastern Medical Oncology Center-Goldsboro
-
Hendersonville, North Carolina, Förenta staterna, 28791
- Margaret R Pardee Memorial Hospital
-
Jacksonville, North Carolina, Förenta staterna, 28546
- Southeastern Medical Oncology Center-Jacksonville
-
Kinston, North Carolina, Förenta staterna, 28501
- ECU Health Oncology Kinston
-
Washington, North Carolina, Förenta staterna, 27889
- Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
-
-
North Dakota
-
Bismarck, North Dakota, Förenta staterna, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Förenta staterna, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Förenta staterna, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Beachwood, Ohio, Förenta staterna, 44122
- UHHS-Chagrin Highlands Medical Center
-
Belpre, Ohio, Förenta staterna, 45714
- Strecker Cancer Center-Belpre
-
Centerville, Ohio, Förenta staterna, 45459
- Miami Valley Hospital South
-
Chillicothe, Ohio, Förenta staterna, 45601
- Adena Regional Medical Center
-
Cleveland, Ohio, Förenta staterna, 44106
- Case Western Reserve University
-
Columbus, Ohio, Förenta staterna, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, Förenta staterna, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Förenta staterna, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Förenta staterna, 43228
- Doctors Hospital
-
Columbus, Ohio, Förenta staterna, 43215
- Grant Medical Center
-
Dayton, Ohio, Förenta staterna, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Förenta staterna, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Förenta staterna, 45409
- Premier Blood and Cancer Center
-
Delaware, Ohio, Förenta staterna, 43015
- Delaware Health Center-Grady Cancer Center
-
Franklin, Ohio, Förenta staterna, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Mansfield, Ohio, Förenta staterna, 44903
- OhioHealth Mansfield Hospital
-
Marietta, Ohio, Förenta staterna, 45750
- Marietta Memorial Hospital
-
Marion, Ohio, Förenta staterna, 43302
- OhioHealth Marion General Hospital
-
Maumee, Ohio, Förenta staterna, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee, Ohio, Förenta staterna, 43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Mentor, Ohio, Förenta staterna, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Middleburg Heights, Ohio, Förenta staterna, 44130
- UH Seidman Cancer Center at Southwest General Hospital
-
Newark, Ohio, Förenta staterna, 43055
- Licking Memorial Hospital
-
Parma, Ohio, Förenta staterna, 44129
- University Hospitals Parma Medical Center
-
Perrysburg, Ohio, Förenta staterna, 43551
- Mercy Health - Perrysburg Hospital
-
Portsmouth, Ohio, Förenta staterna, 45662
- Southern Ohio Medical Center
-
Toledo, Ohio, Förenta staterna, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, Förenta staterna, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Troy, Ohio, Förenta staterna, 45373
- Upper Valley Medical Center
-
Wadsworth, Ohio, Förenta staterna, 44281
- University Hospitals Sharon Health Center
-
Westlake, Ohio, Förenta staterna, 44145
- UH Seidman Cancer Center at Saint John Medical Center
-
Zanesville, Ohio, Förenta staterna, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Förenta staterna, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Förenta staterna, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Oregon
-
Baker City, Oregon, Förenta staterna, 97814
- Saint Alphonsus Cancer Care Center-Baker City
-
Clackamas, Oregon, Förenta staterna, 97015
- Providence Cancer Institute Clackamas Clinic
-
Newberg, Oregon, Förenta staterna, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Förenta staterna, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Portland, Oregon, Förenta staterna, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Förenta staterna, 97225
- Providence Saint Vincent Medical Center
-
-
Pennsylvania
-
Allentown, Pennsylvania, Förenta staterna, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Bethlehem, Pennsylvania, Förenta staterna, 18017
- Lehigh Valley Hospital - Muhlenberg
-
East Stroudsburg, Pennsylvania, Förenta staterna, 18301
- Pocono Medical Center
-
Erie, Pennsylvania, Förenta staterna, 16544
- Saint Vincent Hospital
-
Hazleton, Pennsylvania, Förenta staterna, 18201
- Lehigh Valley Hospital-Hazleton
-
Jefferson Hills, Pennsylvania, Förenta staterna, 15025
- Jefferson Hospital
-
Monroeville, Pennsylvania, Förenta staterna, 15146
- Forbes Hospital
-
Philadelphia, Pennsylvania, Förenta staterna, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Förenta staterna, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, Förenta staterna, 19140
- Temple University Hospital
-
Pittsburgh, Pennsylvania, Förenta staterna, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Förenta staterna, 15224
- West Penn Hospital
-
Wexford, Pennsylvania, Förenta staterna, 15090
- Wexford Health and Wellness Pavilion
-
-
South Carolina
-
Boiling Springs, South Carolina, Förenta staterna, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Easley, South Carolina, Förenta staterna, 29640
- Prisma Health Cancer Institute - Easley
-
Greenville, South Carolina, Förenta staterna, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Förenta staterna, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Förenta staterna, 29605
- Prisma Health Cancer Institute - Butternut
-
Greer, South Carolina, Förenta staterna, 29650
- Prisma Health Cancer Institute - Greer
-
Seneca, South Carolina, Förenta staterna, 29672
- Prisma Health Cancer Institute - Seneca
-
-
South Dakota
-
Sioux Falls, South Dakota, Förenta staterna, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Förenta staterna, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Utah
-
Farmington, Utah, Förenta staterna, 84025
- Farmington Health Center
-
Salt Lake City, Utah, Förenta staterna, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, Förenta staterna, 84106
- University of Utah Sugarhouse Health Center
-
-
Washington
-
Seattle, Washington, Förenta staterna, 98101
- Virginia Mason Medical Center
-
-
West Virginia
-
Huntington, West Virginia, Förenta staterna, 25701
- Edwards Comprehensive Cancer Center
-
Morgantown, West Virginia, Förenta staterna, 26506
- West Virginia University Healthcare
-
-
Wisconsin
-
Appleton, Wisconsin, Förenta staterna, 54911
- ThedaCare Regional Cancer Center
-
Ashland, Wisconsin, Förenta staterna, 54806
- Duluth Clinic Ashland
-
Eau Claire, Wisconsin, Förenta staterna, 54701
- Marshfield Medical Center-EC Cancer Center
-
Madison, Wisconsin, Förenta staterna, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Marshfield, Wisconsin, Förenta staterna, 54449
- Marshfield Medical Center-Marshfield
-
Minocqua, Wisconsin, Förenta staterna, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Förenta staterna, 53149
- ProHealth D N Greenwald Center
-
New Richmond, Wisconsin, Förenta staterna, 54017
- Cancer Center of Western Wisconsin
-
Oconomowoc, Wisconsin, Förenta staterna, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Rice Lake, Wisconsin, Förenta staterna, 54868
- Marshfield Medical Center-Rice Lake
-
Stevens Point, Wisconsin, Förenta staterna, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Waukesha, Wisconsin, Förenta staterna, 53188
- UW Cancer Center at ProHealth Care
-
Waukesha, Wisconsin, Förenta staterna, 53188
- ProHealth Waukesha Memorial Hospital
-
Weston, Wisconsin, Förenta staterna, 54476
- Marshfield Medical Center - Weston
-
-
Wyoming
-
Cody, Wyoming, Förenta staterna, 82414
- Billings Clinic-Cody
-
Sheridan, Wyoming, Förenta staterna, 82801
- Welch Cancer Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
-
Documentation of Disease:
-
Histologic Documentation: Well- or moderately-differentiated neuroendocrine tumors of pancreatic and non-pancreatic (i.e. carcinoid) origin by local pathology
- The pathology report must state ONE of the following: 1) well- or moderately-differentiated neuroendocrine tumor, 2) low- or intermediate-grade neuroendocrine tumor, or 3) carcinoid tumor or atypical carcinoid tumor; documentation of histology from a primary or metastatic site is allowed
- Patients with poorly differentiated neuroendocrine carcinoma, high-grade neuroendocrine carcinoma without specification of differentiation status, adenocarcinoid tumor, or goblet cell carcinoid tumor are not eligible. Patients with well-differentiated grade 3 neuroendocrine tumor are eligible
-
Stage: Locally advanced/unresectable or metastatic disease
-
Tumor Site: Histological documentation of neuroendocrine tumor of pancreatic, gastrointestinal (GI), lung, thymus, other, or unknown primary site; GI, lung, thymus, other, and unknown primary NETs will enroll in the carcinoid tumor cohort of the study
- Functional (i.e., associated with symptoms or clinical syndrome related to hormone secretion by tumor) or nonfunctional tumors are allowed
-
Radiologic Evaluation: Target lesions must have shown evidence of disease progression by Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1 criteria in the 12 months prior to registration; the radiologic images, imaging reports, and clinic notes indicating growth of existing lesions, development of new lesions, or treatment changes must be submitted
-
-
Measurable Disease
- Patients must have measurable disease per RECIST 1.1 by computer tomography (CT) scan or magnetic resonance imaging (MRI)
- Lesions must be accurately measured in at least one dimension (longest diameter to be recorded) as >= 1 cm with CT or MRI (or >= 1.5 cm for lymph nodes); non-measurable disease includes disease smaller than these dimensions or lesions considered truly non-measurable including: leptomeningeal disease, ascites, pleural or pericardial effusion, lymphangitic involvement of skin or lung
-
Prior Treatment
- Patient must have experienced disease progression after receiving or intolerance leading to treatment discontinuation of at least one Food and Drug Administration (FDA)-approved line of therapy (except somatostatin analogs); prior lines of therapy must include one of the following: everolimus, sunitinib, or lutetium Lu 177 dotatate in patients with pancreatic NET; everolimus in patients with lung NET; everolimus or lutetium Lu 177 dotatate in patients with gastrointestinal NET
- Prior treatment (except somatostatin analogs) with biologic therapy, immunotherapy, chemotherapy, investigational agent for malignancy, and/or radiation must be completed at least 28 days prior to registration
- Prior treatment with somatostatin analogs is allowed, and continuation of treatment with somatostatin analogs while on cabozantinib/placebo is allowed provided that the patient has been on a stable dose for at least two months
- Prior systemic treatment with radionuclide therapy must be completed at least 6 weeks prior to registration
- Prior treatment with hepatic artery embolization (including bland embolization, chemoembolization, and selective internal radiation therapy) or ablative therapies is allowed if measurable disease remains outside of the treated area or if there is documented disease progression in a treated site; prior liver-directed or other ablative treatment must be completed at least 28 days prior to registration
- Prior treatment with cabozantinib is not allowed
- Patients should have resolution of any toxic effects of prior therapy (except alopecia and fatigue) to National Cancer Institute (NCI) CTCAE, version 5.0, grade 1 or less
- Patients must have completed any major surgery at least 12 weeks prior to registration and any minor surgery (including uncomplicated tooth extractions) at least 28 days prior to registration; complete wound healing from major surgery must have occurred at least 28 days prior to registration, and complete wound healing from minor surgery must have occurred at least 10 days prior to registration
-
Patient History
- No class III or IV congestive heart failure (CHF) within 6 months of registration
- No clinically significant cardiac arrhythmia within 6 months of registration
- No unstable angina or myocardial infarction (MI) within 6 months of registration
- No thromboembolic events within 6 months of registration (including [incl.] stroke, transient ischemic attack [TIA], deep vein thrombosis [DVT], & pulmonary embolism [PE])
- No known history of congenital long QT syndrome
- No uncontrolled hypertension within 14 days of registration (defined as systolic blood pressure [SBP] >= 150 mmHg and/or diastolic blood pressure [DBP] >= 90 mmHg despite optimal medical management)
- No clinically significant GI bleeding within 6 months of registration
- No clinically significant gastrointestinal abnormalities that may increase the risk for gastrointestinal bleeding within 6 months of registration including, but not limited to: active peptic ulcer, known endoluminal metastatic lesion(s) with history of bleeding, inflammatory bowel disease, or other gastrointestinal conditions with increased risk of perforation
- No GI perforation within 6 months of registration
- No known tumor with invasion into the GI tract from the outside causing increased risk of perforation or bleeding within 28 days of registration
- No radiologic or clinical evidence of pancreatitis
- No known cavitary lung lesions
- No known endobronchial lesions involving the main or lobar bronchi and/or lesions infiltrating major pulmonary vessels that increase the risk of pulmonary hemorrhage; (CT with contrast is recommended to evaluate such lesions)
- No hemoptysis greater than 1/2 teaspoon (2.5 mL) or any other signs of pulmonary hemorrhage within the 3 months prior to registration
- No known tumor invading or encasing any major blood vessels
- No history of non-healing wounds or ulcers within 28 days of registration
- No history of fracture within 28 days of registration
- No brain metastases or cranial epidural disease unless adequately treated, stable, and off steroid support for at least 4 weeks prior to registration
- No known medical condition causing an inability to swallow oral formulations of agents
- No history of allergic reaction attributed to compounds of similar chemical or biological composition to cabozantinib/placebo
- No "currently active" second malignancy other than non-melanoma skin cancers or cervical carcinoma in situ; patients are not considered to have a "currently active" malignancy if they have completed therapy and are free of disease for >= 3 years
-
Concomitant Medications
- Other planned concurrent investigational agents or other tumor directed therapies (chemotherapy, radiation) are not allowed while on this study
- Concurrent use of somatostatin analogs while on cabozantinib/placebo is allowed provided that the patient has been on a stable dose for at least two months
- Full dose oral anticoagulation/antiplatelet therapy is not permitted; low dose aspirin =< 81 mg/day is allowed; anticoagulation with therapeutic doses of low molecular weight heparin (LMWH) is allowed in patients who are on a stable dose of LMWH for at least 6 weeks prior to registration; treatment with warfarin is not allowed; anticoagulation in patients with brain metastases is not permitted
- Chronic concomitant treatment with strong inhibitors of CYP3A4 is not allowed; patients must discontinue the drug at least 14 days prior to registration on the study
- Chronic concomitant treatment with strong CYP3A4 inducers is not allowed; patients must discontinue the drug at least 14 days prior to registration on the study
-
Not pregnant and not nursing
- Women of childbearing potential must have a negative pregnancy test done =< 14 days prior to registration
- A female of childbearing potential is a sexually mature female who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 12 consecutive months (i.e. has had menses at any time in the preceding 12 consecutive months)
-
Age >= 18 years
-
Eastern Cooperative Oncology Group (ECOG) performance status: 0-2
-
Absolute neutrophil count (ANC) >= 1,500/mm^3
-
Hemoglobin >= 9 g/dL
-
Platelet count >= 100,000/mm^3
-
Prothrombin time (PT)/ international normalized ratio (INR), partial thromboplastin time (PTT) < 1.3 x upper limit of normal (ULN)
-
Aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) =< 3 x ULN
-
Total bilirubin =< 1.5 x ULN
- Except in the case of Gilbert disease, in which case total bilirubin must be =< 3 x ULN
-
Creatinine =< 1.5 mg/dL OR creatinine clearance >= 45 mL/min
-
Albumin >= 2.8 g/dL
-
Potassium within normal limits (WNL)
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal thyroid stimulating hormone (TSH), if free T4 is normal and patient is clinically euthyroid, patient is eligible
-
Phosphorus WNL
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
-
Calcium WNL
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
-
Magnesium WNL
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
-
Urine protein to creatinine (UPC) ratio =< 1
-
QT interval corrected for heart rate using Fridericia's formula (QTcF) =< 500 msec
-
TSH WNL
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Arm I (cabozantinib S-malate)
Patients receive cabozantinib S-malate PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study. |
Ancillary studies
Andra namn:
Undergo CT
Andra namn:
Undergo MRI
Andra namn:
Given PO
Andra namn:
Undergo blood and urine sample collection
Andra namn:
Undergo x-ray
Andra namn:
|
|
Placebo-jämförare: Arm II (placebo)
Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression. |
Ancillary studies
Andra namn:
Undergo CT
Andra namn:
Undergo MRI
Andra namn:
Given PO Undergo blood and urine sample collection
Andra namn:
Undergo x-ray
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Progression-free Survival (PFS)
Tidsram: 36 months
|
Will be assessed per Response Evaluation Criteria in Solid Tumors 1.1 determined by retrospective independent central review. Will be compared between treatment arms using the stratified log rank test at one-sided level 0.025. The stratification factors will be used for the analysis. The hazard ratio (HR) for PFS will be estimated using a stratified Cox proportional hazards model, and the 95% confidence interval (CI) for the HR will be provided. Results from an unstratified analysis will also be provided. Kaplan-Meier methodology will be used to estimate the median PFS for each treatment arm, and Kaplan-Meier curves will be produced. Brookmeyer Crowley methodology will be used to construct the 95% CI for the median PFS for each treatment arm. |
36 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Overall Survival (OS)
Tidsram: 60 months
|
The analyses for OS will follow intent-to-treat (ITT) principle and will be conducted separately within each cohort (pancreatic neuroendocrine tumor [NET] and carcinoid tumor). The distribution of OS will be estimated using the method of Kaplan-Meier. The median OS, along with the 95% CI, will be estimated by the two treatment groups. Overall survival will be compared between treatment arms using the stratified log-rank test at a one-sided cumulative 2.5% level of significance. The stratified Cox regression will be used to estimate the HR of OS, along with the 95% CI. A hierarchical approach will be used to control for family-wise type-I error rate, therefore OS will be formally statistically tested only if the primary efficacy endpoint, PFS, is statistically significantly different between the two treatment groups. |
60 months
|
|
Number of Patients Experiencing Grade 3+ Adverse Events (AEs) Graded According to the Common Terminology Criteria for Adverse Events (CTCAE) and Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Tidsram: 60 months
|
For CTCAE data, the frequency tables will be reviewed to determine the patterns. The overall adverse event rates will be compared between treatment groups using Chi-square test (or Fisher's exact test if the data in contingency table is sparse). PRO-CTCAE data will, at minimum, be analyzed similarly to CTCAE data. The initial analysis of each PRO-CTCAE item will use all available scores in an analysis which mirrors the approach used for the CTCAE data. Supplemental analysis will use model-based multiple imputation incorporating baseline patient characteristics and physician-rated performance status. CTCAE data may be incorporated as auxiliary data into multiple imputation models for AEs which are captured by both PRO-CTCAE and CTCAE. Results from supplemental analysis will be descriptively compared to the results of the initial analysis to assess the robustness of results to missing data. Additional analyses of PRO-CTCAE data beyond those specified above may be undertaken. |
60 months
|
|
Radiographic Response Rate
Tidsram: 36 months
|
Will be defined as the proportion of patients in each arm whose best response is either complete response (CR) or partial response (PR). Radiographic response rate for both cohorts: the analyses for confirmed radiographic response rate will follow the ITT principle and will be conducted separately within each cohort (pancreatic NET and carcinoid tumor). The proportion of patients with either confirmed CR or confirmed PR as their best response will be estimated using point estimates and 95% confidence intervals. Radiographic response rate will be compared between treatment arms using the 2-sample z-test to compare sample proportion at a one-sided 2.5% level of significance. |
36 months
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Jennifer A Chan, Alliance for Clinical Trials in Oncology
Publikationer och användbara länkar
Allmänna publikationer
- Kunz PL. Angiogenesis inhibitors in neuroendocrine tumours: finally coming of age. Lancet Oncol. 2020 Nov;21(11):1395-1397. doi: 10.1016/S1470-2045(20)30560-X. No abstract available.
- Chan JA, Geyer S, Zemla T, Knopp MV, Behr S, Pulsipher S, Ou FS, Dueck AC, Acoba J, Shergill A, Wolin EM, Halfdanarson TR, Konda B, Trikalinos NA, Tawfik B, Raj N, Shaheen S, Vijayvergia N, Dasari A, Strosberg JR, Kohn EC, Kulke MH, O'Reilly EM, Meyerhardt JA. Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med. 2025 Feb 13;392(7):653-665. doi: 10.1056/NEJMoa2403991. Epub 2024 Sep 16.
- Strosberg JR, Zemla T, Geyer S, Pulsipher S, Ou FS, Behr S, Raj N, Vijayvergia N, Dasari A, O'Reilly EM, Meyerhardt JA, Wolin EM, Halfdanarson TR, Chan JA. Cabozantinib for advanced grade 3 neuroendocrine tumors: subgroup analysis of the phase 3 CABINET trial (Alliance A021602). Endocr Relat Cancer. 2026 Jan 24;33(1):e250415. doi: 10.1530/ERC-25-0415. Print 2026 Jan 1.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Sjukdomar i det endokrina systemet
- Neoplasmer efter plats
- Neoplasmer
- Neoplasmer efter histologisk typ
- Neoplasmer i matsmältningssystemet
- Matsmältningssystemets sjukdomar
- Neoplasmer i endokrina körtel
- Bukspottkörtelsjukdomar
- Neoplasmer, körtel och epitel
- Adenom
- Neuroektodermala tumörer
- Neoplasmer, könsceller och embryonala
- Neoplasmer, nervvävnad
- Pankreatiska neoplasmer
- Neuroendokrina tumörer
- Adenom, öcell
- Icke -fungerande pankreatisk endokrin tumör
- Undersökningstekniker
- Kliniska laboratorietekniker
- Diagnostiska tekniker och procedurer
- Diagnos
- Fysiska fenomen
- Utrustning och förnödenheter
- Kemitekniker, analytiska
- Spektrumanalys
- Elektromagnetiska fenomen
- Magnetfenomen
- Elektromagnetisk strålning
- Strålning
- Strålning, joniserande
- Provhantering
- Magnetresonansspektroskopi
- Röntgenstrålar
- cabozantinib
- Fantom, avbildning
Andra studie-ID-nummer
- NCI-2017-02297
- U10CA180821 (U.S.S. NIH-anslag/kontrakt)
- NCI-2017-02297 (Registeridentifierare: CTRP (Clinical Trial Reporting Program))
- A021602 (Annan identifierare: CTEP)
- A021602 (Annan identifierare: Alliance for Clinical Trials in Oncology)
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .